Imaging of serotonin transporters and its blockade by citalopram in patients with major depression using a novel SPECT ligand [123I]-ADAM

[1]  D. Puigdemont,et al.  SPECT of serotonin transporters using 123I-ADAM: optimal imaging time after bolus injection and long-term test-retest in healthy volunteers. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2]  A. Alavi,et al.  123I-ADAM binding to serotonin transporters in patients with major depression and healthy controls: a preliminary study. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[3]  A. Schatzberg,et al.  Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression. , 2004, Archives of general psychiatry.

[4]  Robert B. Innis,et al.  Brain serotonin transporter availability predicts treatment response to selective serotonin reuptake inhibitors , 2004, Biological Psychiatry.

[5]  U. Müller,et al.  Advances in in vivo imaging of serotonergic neurons in neuropsychiatric disorders , 2004, Neuroscience & Biobehavioral Reviews.

[6]  J. Tiihonen,et al.  123I-beta-CIT binding and recovery from depression. A six-month follow-up study. , 2004, European archives of psychiatry and clinical neuroscience.

[7]  A. Alavi,et al.  Biodistribution and imaging with (123)I-ADAM: a serotonin transporter imaging agent. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[8]  Sylvain Houle,et al.  Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study. , 2004, The American journal of psychiatry.

[9]  Cheng-Yu Chen,et al.  Imaging serotonin transporters with 123I-ADAM brain SPECT in healthy non-human primates , 2004, Nuclear medicine communications.

[10]  J. Vercouillie,et al.  ADAM is an effective tool for in vivo study of serotonergic function: Validation in rat models , 2004, Synapse.

[11]  T. Yen,et al.  Characterization of the binding sites for 123I-ADAM and the relationship to the serotonin transporter in rat and mouse brains using quantitative autoradiography. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[12]  Marc Laruelle,et al.  Central serotonin transporter availability measured with [123I]beta-CIT SPECT in relation to serotonin transporter genotype. , 2004, The American journal of psychiatry.

[13]  B. Müller-Oerlinghausen,et al.  High platelet-serotonin uptake activity is associated with a rapid response in depressed patients treated with amitriptyline , 2003, Neuroscience Letters.

[14]  Yoshiro Okubo,et al.  High levels of serotonin transporter occupancy with low-dose clomipramine in comparative occupancy study with fluvoxamine using positron emission tomography. , 2003, Archives of general psychiatry.

[15]  C. Nemeroff,et al.  Serotonin Transporter: A Potential Substrate in the Biology of Suicide , 2003, Neuropsychopharmacology.

[16]  M. Vaswani,et al.  Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review , 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[17]  Stephen A. Williams,et al.  Changes in Human In vivo Serotonin and Dopamine Transporter Availabilities during Chronic Antidepressant Administration , 2003, Neuropsychopharmacology.

[18]  Ulrich Müller,et al.  Is correction for age necessary in neuroimaging studies of the central serotonin transporter? , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[19]  Alan A. Wilson,et al.  Comparative Evaluation in Nonhuman Primates of Five PET Radiotracers for Imaging the Serotonin Transporters: [11C]McN 5652, [11C]ADAM, [11C]DASB, [11C]DAPA, and [11C]AFM , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[20]  B. Müller-Oerlinghausen,et al.  High platelet-5HT uptake activity is associated with a rapid response in depressed patients treated with amitriptyline , 2002, European Neuropsychopharmacology.

[21]  P. Bech,et al.  Citalopram dose-response revisited using an alternative psychometric approach to evaluate clinical effects of four fixed citalopram doses compared to placebo in patients with major depression , 2002, Psychopharmacology.

[22]  Mark Slifstein,et al.  Positron emission tomography: imaging and quantification of neurotransporter availability. , 2002, Methods.

[23]  F. Yasuno,et al.  Serotonin transporter binding in patients with mood disorders: a PET study with [11C](+)McN5652 , 2002, Biological Psychiatry.

[24]  Alan A. Wilson,et al.  Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: a [(11)C]DASB PET imaging study. , 2001, The American journal of psychiatry.

[25]  S. Horschitz,et al.  Structure, function and regulation of the 5-hydroxytryptamine (serotonin) transporter. , 2001, Biochemical Society transactions.

[26]  P. Acton,et al.  Quantification of serotonin transporters in nonhuman primates using [(123)I]ADAM and SPECT. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[27]  M Fujita,et al.  Sex differences in [123I]β‐CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers , 2001, Synapse.

[28]  S. Kasper,et al.  [123I] β-CIT and single photon emission computed tomography reveal reduced brain serotonin transporter availability in bulimia nervosa , 2001, Biological Psychiatry.

[29]  P. Acton,et al.  Selective in vitro and in vivo binding of [125I]ADAM to serotonin transporters in rat brain , 2000, Synapse.

[30]  Alan A. Wilson,et al.  Imaging the serotonin transporter with positron emission tomography: initial human studies with [11C]DAPP and [11C]DASB , 2000, European Journal of Nuclear Medicine.

[31]  I. Moilanen,et al.  Elevated hypothalamic/midbrain serotonin (monoamine) transporter availability in depressive drug-naive children and adolescents , 2000, Molecular Psychiatry.

[32]  A. Berghöfer,et al.  Serotonergic platelet variables in unmedicated patients suffering from major depression and healthy subjects: relationship between 5HT content and 5HT uptake. , 2000, Life sciences.

[33]  P. Acton,et al.  2-((2-((dimethylamino)methyl)phenyl)thio)-5-iodophenylamine (ADAM): an improved serotonin transporter ligand. , 2000, Nuclear medicine and biology.

[34]  Alexander Neumeister,et al.  [123I]-β-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder , 2000, Biological Psychiatry.

[35]  Alexander Neumeister,et al.  Seasonal variation of availability of serotonin transporter binding sites in healthy female subjects as measured by [123I]-2β-carbomethoxy-3β- (4-iodophenyl)tropane and single photon emission computed tomography , 2000, Biological Psychiatry.

[36]  J John Mann,et al.  Role of the Serotonergic System in the Pathogenesis of Major Depression and Suicidal Behavior , 1999, Neuropsychopharmacology.

[37]  S. Kasper,et al.  In vivo visualization of serotonin transporters in the human brain during fluoxetine treatment , 1999, European Neuropsychopharmacology.

[38]  Linda Carpenter,et al.  Reduced brain serotonin transporter availability in major depression as measured by [123I]-2β-carbomethoxy-3β-(4-iodophenyl)tropane and single photon emission computed tomography , 1998, Biological Psychiatry.

[39]  Robert B Innis,et al.  Imaging of the serotonergic system: interactions of neuroanatomical and functional abnormalities of depression , 1998, Biological Psychiatry.

[40]  N. Volkow,et al.  Distribution Volume Ratios without Blood Sampling from Graphical Analysis of PET Data , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[41]  G. Goodwin,et al.  Polymorphism in serotonin transporter gene associated with susceptibility to major depression , 1996, The Lancet.

[42]  C. Halldin,et al.  Pet study of [11C] β‐CIT binding to monoamine transporters in the monkey and human brain , 1994, Synapse.

[43]  C. Nemeroff,et al.  Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. , 1994, Clinical chemistry.

[44]  G. Rudnick,et al.  From synapse to vesicle: the reuptake and storage of biogenic amine neurotransmitters. , 1993, Biochimica et biophysica acta.

[45]  M. Palkovits,et al.  5-HT uptake sites and 5-HT2 receptors in brain of antidepressant-free suicide victims/depressives: increase in 5-HT2 sites in cortex and amygdala , 1993, Brain Research.

[46]  F I Carroll,et al.  High‐affinity binding of [125I]RTI‐55 to dopamine and serotonin transporters in rat brain , 1992, Synapse.

[47]  P B Hoffer,et al.  [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane: high-affinity SPECT radiotracer of monoamine reuptake sites in brain. , 1991, Journal of medicinal chemistry.

[48]  H. Meltzer.  Role of Serotonin in Depression a , 1990, Annals of the New York Academy of Sciences.

[49]  S. Snyder,et al.  Selective labeling of serotonin uptake sites in rat brain by [3H]citalopram contrasted to labeling of multiple sites by [3H]imipramine. , 1987, The Journal of pharmacology and experimental therapeutics.

[50]  Lee-Tzuu Chang,et al.  A Method for Attenuation Correction in Radionuclide Computed Tomography , 1978, IEEE Transactions on Nuclear Science.

[51]  D. Murphy,et al.  Isolation of a cDNA encoding the human brain serotonin transporter , 2005, Journal of Neural Transmission / General Section JNT.

[52]  I. Podreka,et al.  β-CIT SPECT demonstrates blockade of 5HT-uptake sites by citalopram in the human brain in vivo , 2005, Journal of Neural Transmission / General Section JNT.

[53]  K. Bergström,et al.  Biodistribution and radiation dosimetry of [123I]ADAM in healthy human subjects: preliminary results , 2002, European Journal of Nuclear Medicine and Molecular Imaging.

[54]  J Tauscher,et al.  Imaging serotonin and dopamine transporters with 123I-beta-CIT SPECT: binding kinetics and effects of normal aging. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[55]  P. Acton,et al.  Single-photon emission tomography imaging of serotonin transporters in the nonhuman primate brain with [(123)I]ODAM. , 1999, European journal of nuclear medicine.

[56]  P. Riederer,et al.  Mosaicism for a serotonin transporter gene promoter-associated deletion: decreased recombination in depression , 1999, Journal of Neural Transmission.

[57]  P. Acton,et al.  Single-photon emission tomography imaging of serotonin transporters in the non-human primate brain with the selective radioligand [(123)I]IDAM. , 1999, European journal of nuclear medicine.

[58]  C. Nemeroff,et al.  The serotonin transporter and depression , 1998, Depression and anxiety.

[59]  M Laruelle,et al.  SPECT imaging of dopamine and serotonin transporters in nonhuman primate brain. , 1994, NIDA research monograph.

[60]  H N Wagner,et al.  A PET radiotracer for studying serotonin uptake sites: carbon-11-McN-5652Z. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.